Progressions of the correlation between lipid metabolism and immune infiltration characteristics in gastric cancer and identification of BCHE as a potential biomarker

BackgroundGlobally, gastric cancer (GC) is a category of prevalent malignant tumors. Its high occurrence and fatality rates represent a severe threat to public health. According to recent research, lipid metabolism (LM) reprogramming impacts immune cells’ ordinary function and is critical for the on...

Full description

Bibliographic Details
Main Authors: Shibo Wang, Xiaojuan Huang, Shufen Zhao, Jing Lv, Yi Li, Shasha Wang, Jing Guo, Yan Wang, Rui Wang, Mengqi Zhang, Wensheng Qiu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1327565/full
_version_ 1797338402998190080
author Shibo Wang
Xiaojuan Huang
Shufen Zhao
Jing Lv
Yi Li
Shasha Wang
Jing Guo
Yan Wang
Rui Wang
Mengqi Zhang
Wensheng Qiu
author_facet Shibo Wang
Xiaojuan Huang
Shufen Zhao
Jing Lv
Yi Li
Shasha Wang
Jing Guo
Yan Wang
Rui Wang
Mengqi Zhang
Wensheng Qiu
author_sort Shibo Wang
collection DOAJ
description BackgroundGlobally, gastric cancer (GC) is a category of prevalent malignant tumors. Its high occurrence and fatality rates represent a severe threat to public health. According to recent research, lipid metabolism (LM) reprogramming impacts immune cells’ ordinary function and is critical for the onset and development of cancer. Consequently, the article conducted a sophisticated bioinformatics analysis to explore the potential connection between LM and GC.MethodsWe first undertook a differential analysis of the TCGA queue to recognize lipid metabolism-related genes (LRGs) that are differentially expressed. Subsequently, we utilized the LASSO and Cox regression analyses to create a predictive signature and validated it with the GSE15459 cohort. Furthermore, we examined somatic mutations, immune checkpoints, tumor immune dysfunction and exclusion (TIDE), and drug sensitivity analyses to forecast the signature’s immunotherapy responses.ResultsKaplan-Meier (K-M) curves exhibited considerably longer OS and PFS (p<0.001) of the low-risk (LR) group. PCA analysis and ROC curves evaluated the model’s predictive efficacy. Additionally, GSEA analysis demonstrated that a multitude of carcinogenic and matrix-related pathways were much in the high-risk (HR) group. We then developed a nomogram to enhance its clinical practicality, and we quantitatively analyzed tumor-infiltrating immune cells (TIICs) using the CIBERSORT and ssGSEA algorithms. The low-risk group has a lower likelihood of immune escape and more effective in chemotherapy and immunotherapy. Eventually, we selected BCHE as a potential biomarker for further research and validated its expression. Next, we conducted a series of cell experiments (including CCK-8 assay, Colony formation assay, wound healing assay and Transwell assays) to prove the impact of BCHE on gastric cancer biological behavior.DiscussionOur research illustrated the possible consequences of lipid metabolism in GC, and we identified BCHE as a potential therapeutic target for GC. The LRG-based signature could independently forecast the outcome of GC patients and guide personalized therapy.
first_indexed 2024-03-08T09:29:40Z
format Article
id doaj.art-264011482c8546aca2bc66ce8b8b4816
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-03-08T09:29:40Z
publishDate 2024-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-264011482c8546aca2bc66ce8b8b48162024-01-31T04:37:57ZengFrontiers Media S.A.Frontiers in Immunology1664-32242024-01-011510.3389/fimmu.2024.13275651327565Progressions of the correlation between lipid metabolism and immune infiltration characteristics in gastric cancer and identification of BCHE as a potential biomarkerShibo Wang0Xiaojuan Huang1Shufen Zhao2Jing Lv3Yi Li4Shasha Wang5Jing Guo6Yan Wang7Rui Wang8Mengqi Zhang9Wensheng Qiu10Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, ChinaDepartment of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, ChinaDepartment of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, ChinaDepartment of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, ChinaDepartment of Dermatology, The Affiliated Hospital of Qingdao University, Qingdao, ChinaDepartment of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, ChinaDepartment of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, ChinaDepartment of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, ChinaDepartment of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, ChinaDepartment of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, ChinaDepartment of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, ChinaBackgroundGlobally, gastric cancer (GC) is a category of prevalent malignant tumors. Its high occurrence and fatality rates represent a severe threat to public health. According to recent research, lipid metabolism (LM) reprogramming impacts immune cells’ ordinary function and is critical for the onset and development of cancer. Consequently, the article conducted a sophisticated bioinformatics analysis to explore the potential connection between LM and GC.MethodsWe first undertook a differential analysis of the TCGA queue to recognize lipid metabolism-related genes (LRGs) that are differentially expressed. Subsequently, we utilized the LASSO and Cox regression analyses to create a predictive signature and validated it with the GSE15459 cohort. Furthermore, we examined somatic mutations, immune checkpoints, tumor immune dysfunction and exclusion (TIDE), and drug sensitivity analyses to forecast the signature’s immunotherapy responses.ResultsKaplan-Meier (K-M) curves exhibited considerably longer OS and PFS (p<0.001) of the low-risk (LR) group. PCA analysis and ROC curves evaluated the model’s predictive efficacy. Additionally, GSEA analysis demonstrated that a multitude of carcinogenic and matrix-related pathways were much in the high-risk (HR) group. We then developed a nomogram to enhance its clinical practicality, and we quantitatively analyzed tumor-infiltrating immune cells (TIICs) using the CIBERSORT and ssGSEA algorithms. The low-risk group has a lower likelihood of immune escape and more effective in chemotherapy and immunotherapy. Eventually, we selected BCHE as a potential biomarker for further research and validated its expression. Next, we conducted a series of cell experiments (including CCK-8 assay, Colony formation assay, wound healing assay and Transwell assays) to prove the impact of BCHE on gastric cancer biological behavior.DiscussionOur research illustrated the possible consequences of lipid metabolism in GC, and we identified BCHE as a potential therapeutic target for GC. The LRG-based signature could independently forecast the outcome of GC patients and guide personalized therapy.https://www.frontiersin.org/articles/10.3389/fimmu.2024.1327565/fullgastric cancerlipid metabolismprognostic signatureTIICsBChEimmunotherapy
spellingShingle Shibo Wang
Xiaojuan Huang
Shufen Zhao
Jing Lv
Yi Li
Shasha Wang
Jing Guo
Yan Wang
Rui Wang
Mengqi Zhang
Wensheng Qiu
Progressions of the correlation between lipid metabolism and immune infiltration characteristics in gastric cancer and identification of BCHE as a potential biomarker
Frontiers in Immunology
gastric cancer
lipid metabolism
prognostic signature
TIICs
BChE
immunotherapy
title Progressions of the correlation between lipid metabolism and immune infiltration characteristics in gastric cancer and identification of BCHE as a potential biomarker
title_full Progressions of the correlation between lipid metabolism and immune infiltration characteristics in gastric cancer and identification of BCHE as a potential biomarker
title_fullStr Progressions of the correlation between lipid metabolism and immune infiltration characteristics in gastric cancer and identification of BCHE as a potential biomarker
title_full_unstemmed Progressions of the correlation between lipid metabolism and immune infiltration characteristics in gastric cancer and identification of BCHE as a potential biomarker
title_short Progressions of the correlation between lipid metabolism and immune infiltration characteristics in gastric cancer and identification of BCHE as a potential biomarker
title_sort progressions of the correlation between lipid metabolism and immune infiltration characteristics in gastric cancer and identification of bche as a potential biomarker
topic gastric cancer
lipid metabolism
prognostic signature
TIICs
BChE
immunotherapy
url https://www.frontiersin.org/articles/10.3389/fimmu.2024.1327565/full
work_keys_str_mv AT shibowang progressionsofthecorrelationbetweenlipidmetabolismandimmuneinfiltrationcharacteristicsingastriccancerandidentificationofbcheasapotentialbiomarker
AT xiaojuanhuang progressionsofthecorrelationbetweenlipidmetabolismandimmuneinfiltrationcharacteristicsingastriccancerandidentificationofbcheasapotentialbiomarker
AT shufenzhao progressionsofthecorrelationbetweenlipidmetabolismandimmuneinfiltrationcharacteristicsingastriccancerandidentificationofbcheasapotentialbiomarker
AT jinglv progressionsofthecorrelationbetweenlipidmetabolismandimmuneinfiltrationcharacteristicsingastriccancerandidentificationofbcheasapotentialbiomarker
AT yili progressionsofthecorrelationbetweenlipidmetabolismandimmuneinfiltrationcharacteristicsingastriccancerandidentificationofbcheasapotentialbiomarker
AT shashawang progressionsofthecorrelationbetweenlipidmetabolismandimmuneinfiltrationcharacteristicsingastriccancerandidentificationofbcheasapotentialbiomarker
AT jingguo progressionsofthecorrelationbetweenlipidmetabolismandimmuneinfiltrationcharacteristicsingastriccancerandidentificationofbcheasapotentialbiomarker
AT yanwang progressionsofthecorrelationbetweenlipidmetabolismandimmuneinfiltrationcharacteristicsingastriccancerandidentificationofbcheasapotentialbiomarker
AT ruiwang progressionsofthecorrelationbetweenlipidmetabolismandimmuneinfiltrationcharacteristicsingastriccancerandidentificationofbcheasapotentialbiomarker
AT mengqizhang progressionsofthecorrelationbetweenlipidmetabolismandimmuneinfiltrationcharacteristicsingastriccancerandidentificationofbcheasapotentialbiomarker
AT wenshengqiu progressionsofthecorrelationbetweenlipidmetabolismandimmuneinfiltrationcharacteristicsingastriccancerandidentificationofbcheasapotentialbiomarker